Ebola Death Toll in Congo Rises to 304 Amid Ongoing Outbreak

The Ebola outbreak in the Democratic Republic of Congo continues to claim lives, with the death toll now at 304 and 1,155 cases confirmed, according to the Ministry of Communication in Kinshasa. The epidemic remains active in the provinces of Ituri, North Kivu, and South Kivu, with Ituri in the northeast bearing the brunt of the outbreak.

Ebola fever is a life-threatening illness transmitted through bodily fluids and contact. The current outbreak is proving particularly difficult to contain, partly because there is neither a vaccine nor a specific therapy for the Bundibugyo strain of the virus.

However, hope is on the horizon as clinical trials for new drugs are slated to begin next week. The antiviral drug Remdesivir, developed by U.S. and Egyptian manufacturers, has already arrived in Congo. This medication is intended as a prophylactic, to be administered after contact with the Ebola virus. Another U.S.-developed treatment, MBP134, is expected to arrive in the coming days, and several companies are also working on additional vaccine candidates.